Latest in Viking Therapeutics’ stock soars 18% as data on oral weight loss drug looms
Sort by
744 items
-
Business - MarketWatch
Gevo stock soars on $1.46 billion DOE loan for sustainable aviation fuel plant
Shares of Gevo Inc. are climbing 38.2% in premarket trades Thursday after the renewable chemicals and biofuels company received a commitment for a $1.46 billion loan from the U.S. Department of ...October 17 -
Top stories - CBS News
Weight loss drugs could help patients struggling with addiction, study says
A new study shows diabetes drugs like Mounjaro and Ozempic, which people also take to lose weight, may help patients suffering from addiction. CBS News contributor Dr. Celine Gounder explains.October 17 -
Sports - CBS Sports
Sawed posts and sweet cigars: An oral history of the 2022 Tennessee-Alabama epic
The year was 2022. Tennessee had not beaten Alabama since 2006. Then came Heupel, Hooker, Hyatt and a whole host of crazies.October 17 -
World - Financial Times
Weight-loss drugs show promise in tackling opioid and alcohol abuse
Analysis points to potential of drugs such as Ozempic beyond tackling obesity and diabetesOctober 17 -
Sports - ESPN
Heartache, near misses, elusive title dream: Oral history of Liberty's tortured past
An original franchise when the WNBA launched in 1997, the star-crossed Liberty are still chasing their first title.October 16 -
Business - MarketWatch
Phunware stock climbs 18% after mobile-advertising company touts generative AI
Shares of Phunware Inc. rose 17.6% on Wednesday after the mobile-advertising software company gave a business update and announced the development of a new generative-AI platform.October 16 -
Business - MarketWatch
Small-cap biotech Jaguar Health’s stock jumps as it launches treatment for a painful side effect of cancer treatment
The stock of small-cap biotech Jaguar Health Inc. rose 7% on Wednesday, after the company launched its gelclair treatment for oral mucositis, a common side effect suffered by head and neck cancer ...October 16 -
Top stories - NBC News
Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.
U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.October 16 -
Top stories - BBC News
NHS needs better plan around weight loss jabs, warn experts
Experts call for an urgent review of obesity treatment services amid booming demand for weight loss jabs.October 16 -
World - The Guardian
Weight-loss drug firm accused of prioritising profits after halting insulin pen production
Novo Nordisk’s decision will force people in developing countries to use outdated glass vials and syringes, warn campaigners. The pharmaceutical company behind injectable weight-loss drugs has been ...October 16 -
Business - CNBC
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Medicare coverage of the drugs would up federal spending by $35 billion from 2026 to 2034. Meanwhile, CNBC tests Abbott's continuous glucose monitor Lingo.October 15 -
Business - The New York Times
Trump Media’s Stock Price Soars, Adding $2 Billion to Trump’s Stake
The sharp rise in the share price of the parent of Truth Social has added about $2 billion to the net worth of former President Donald J. Trump.October 15 - Donald Trump -
Business - CNBC
Citigroup earnings top estimates, but stock falls as bank boosts loan loss reserves
The bank's third-quarter report was stronger than Wall Street expected but still showed a year-over-year decline in earnings.October 15 -
Top stories - BBC News
Weight Loss Jabs for Jobs?
Health Secretary says jabs could be given to help people get back into work.October 15 -
World - The New York Times
Could Weight-Loss Drugs Help Get People Back to Work? The U.K. Wants to Find Out.
The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will study the impact of a weight-loss drug on work and productivity.October 15 -
-
Top stories - BBC News
Unemployed could get weight loss jabs to return to work
The health secretary announces trials to explore the effect of weight loss drugs on worklessness.October 15 -
Business - CNBC
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.October 15 -
Top stories - BBC News
Will weight-loss drugs help jobless get back into work?
Ministers are lauding the new generation of weight-loss drugs - but are they really the solution?October 15 -
Sports - CBS Sports
NFL 2024 playoff picture, standings for Week 7: Chiefs, Vikings lone unbeaten teams; Falcons soaring in NFC
An early look at the playoff standings with one third of the season completedOctober 15 - NFL -
Top stories - NBC News
Maine shooting survivors claim Army negligence and FDA's weight-loss drug decision: Morning Rundown
Detroit, TCF Center, 2024 election, Harris in Pennsylvania, Lewiston Maine shooting, Trump rally shooting survivors, giant pandas at National Zoo, Mount EverestOctober 15 -
World - The New York Times
Therapeutic Food Shortage Puts African Children at Risk of Starvation, U.N. Agency Says
Supplies of a highly nutritious treatment are running out, according to UNICEF.October 15 -
Politics - The Hill
FDA will reconsider decision barring copycat versions of Lilly weight loss drug
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding ...October 14 -
Business - MarketWatch
Longboard Pharmaceuticals’ stock soars amid Lundbeck’s $2.6 billion deal to acquire the company
H. Lundbeck plans to acquire Longboard Pharmaceuticals in a $2.6 billion deal, the companies announced Monday.October 14 -
Business - MarketWatch
B. Riley’s stock soars 30% after bank agrees to sell Great American to Oaktree for almost $400 million
Investment bank’s stock is down 73% in the year to date amid regulatory fallout over a loanOctober 14 -
Business - MarketWatch
Amgen’s stock falls as analyst warns that hype around obesity drug is baked in
Truist analyst Srikripa Devarakonda backs away from bullish call as competition mutes potential for biotech’s drug pipeline.October 14 -
Top stories - The New York Times
In Texas, Execution Looms Despite Questions in Shaken Baby Case
Robert Roberson could be the first person put to death in connection with shaken baby syndrome. The state’s highest criminal court ruled in another case that the science had changed.October 14